NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 171 filers reported holding NEOGENOMICS INC in Q3 2018. The put-call ratio across all filers is 0.09 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $425,906 | -11.8% | 30,707 | 0.0% | 0.00% | -50.0% |
Q1 2024 | $482,714 | -2.8% | 30,707 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $496,839 | +57.5% | 30,707 | +19.7% | 0.00% | +100.0% |
Q3 2023 | $315,409 | -10.0% | 25,643 | +17.6% | 0.00% | -50.0% |
Q2 2023 | $350,422 | -7.7% | 21,806 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $379,642 | +112.8% | 21,806 | +12.9% | 0.00% | +100.0% |
Q4 2022 | $178,415 | +32.2% | 19,309 | +23.5% | 0.00% | 0.0% |
Q3 2022 | $135,000 | +6.3% | 15,635 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $127,000 | -33.2% | 15,635 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $190,000 | -64.4% | 15,635 | 0.0% | 0.00% | -66.7% |
Q4 2021 | $533,000 | -2.6% | 15,635 | +37.9% | 0.00% | 0.0% |
Q3 2021 | $547,000 | +6.8% | 11,340 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $512,000 | -6.4% | 11,340 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $547,000 | -21.7% | 11,340 | -12.6% | 0.00% | -25.0% |
Q4 2020 | $699,000 | +56.7% | 12,982 | +7.5% | 0.00% | +33.3% |
Q3 2020 | $446,000 | +19.3% | 12,081 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $374,000 | +40.6% | 12,081 | +25.4% | 0.00% | +50.0% |
Q1 2020 | $266,000 | +9.5% | 9,632 | +16.1% | 0.00% | 0.0% |
Q4 2019 | $243,000 | +120.9% | 8,298 | +43.6% | 0.00% | +100.0% |
Q3 2019 | $110,000 | -0.9% | 5,778 | +14.7% | 0.00% | 0.0% |
Q2 2019 | $111,000 | +7.8% | 5,039 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $103,000 | +41.1% | 5,039 | -13.4% | 0.00% | 0.0% |
Q4 2018 | $73,000 | -18.0% | 5,818 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $89,000 | +17.1% | 5,818 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $76,000 | +61.7% | 5,818 | 0.0% | 0.00% | – |
Q1 2018 | $47,000 | -9.6% | 5,818 | 0.0% | 0.00% | – |
Q4 2017 | $52,000 | +33.3% | 5,818 | +64.8% | 0.00% | – |
Q3 2017 | $39,000 | +21.9% | 3,530 | 0.0% | 0.00% | – |
Q2 2017 | $32,000 | +14.3% | 3,530 | 0.0% | 0.00% | – |
Q1 2017 | $28,000 | -6.7% | 3,530 | 0.0% | 0.00% | – |
Q4 2016 | $30,000 | -38.8% | 3,530 | -41.2% | 0.00% | -100.0% |
Q3 2016 | $49,000 | +2.1% | 6,001 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $48,000 | – | 6,001 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,615,513 | $13,166,000 | 9.25% |
First Light Asset Management, LLC | 2,715,487 | $22,131,000 | 2.58% |
PERKINS CAPITAL MANAGEMENT INC | 202,550 | $1,651,000 | 1.71% |
Greenhouse Funds LLLP | 1,395,035 | $11,370,000 | 1.25% |
EMERALD ADVISERS, LLC | 1,213,353 | $9,889,000 | 0.51% |
Bullseye Asset Management LLC | 108,272 | $883,000 | 0.50% |
EMERALD MUTUAL FUND ADVISERS TRUST | 959,858 | $7,823,000 | 0.45% |
OAK FAMILY ADVISORS, LLC | 88,604 | $722,000 | 0.36% |
MPM BioImpact LLC | 135,573 | $1,105,000 | 0.31% |
Fernwood Investment Management, LLC | 70,285 | $573,000 | 0.25% |